 mononuclear phagocyt system dysfunct murin sle abnorm clearanc kinet clinic diseas sever studi abnorm immun clearanc murin model system lupu erythematosu sle consist defect mononuclear phagocyt function sle-pron mice mechan immun clearanc murin sle techniqu kinet analysi studi radiolabel immunoglobulin-sensit red blood cell normal balb/c autoimmun bxsb mrl-lpr/lpr new zealand black nzb new zealand black/whit nzb/w mice clearanc studi mice complement-fix rabbit igg blood cell antibodi clearanc rate constant complement- fc-mediat clearanc function complement-medi sequestr deactiv releas complement-depend phagocytosi fc-mediat sequestr phagocytosi bxsb male mrl-lpr/lpr femal male nzb femal nzb/w femal male mice fc-mediat clearanc function control balb/c mice defect fc-mediat clearanc present strain autoimmun mice month age onset serolog clinic diseas activ nzb mice abnorm complement-medi clearanc mrl-lpr/lpr femal male mice nzb femal nzb/w femal male mice bxsb mice mrl-lpr/lpr mice complement-medi sequestr complement-depend phagocytosi present week age contrast chang complement-medi clearanc nzb nzb/w mice decreas deactiv releas enhanc earli phase clearanc valu new zealand mice month age serolog clinic diseas activ Fc receptor function studi earli progress uniform defect fc-mediat clearanc murin strain sle complement-medi clearanc lupus-pron mice sever impair mrl-lpr/lpr normal function bxsb clearanc nzb nzb/w mice clearanc new zealand mice decreas deactiv releas antibodi sensit cell turn phagocytosi sensit cell complement-depend process